Related Experiment Video
Updated: Dec 18, 2025
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
5.2K
Oncocardiology: new challenges, new opportunities.
Lars Michel1, Dirk Schadendorf2,3, Tienush Rassaf4
1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, Medical Faculty, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Herz
|June 10, 2020
Summary
Cancer patients face higher cardiovascular disease risks. Oncocardiology addresses these risks, focusing on early detection and treatment of cancer therapy-related cardiovascular side effects for improved patient outcomes.
Area of Science:
- Oncology and Cardiology
- Cardio-oncology
- Cancer Therapeutics
Background:
- Cancer patients have increased cardiovascular disease (CVD) risk, a major cause of morbidity and mortality.
- Advances in cancer treatment lead to more long-term survivors, increasing the importance of managing CVD complications.
- New cancer therapies reveal novel cardiovascular side effects, necessitating specialized care.
Purpose of the Study:
- To review current developments in cardio-oncology, focusing on cancer therapy advances and clinical challenges.
- To characterize cardiovascular side effects of targeted cancer therapies.
- To outline advances in cardiovascular diagnostics and integration of cardio-oncology into healthcare.
Main Methods:
- Literature review of current developments in cancer therapy and cardio-oncology.
- Characterization of cardiovascular side effects associated with targeted cancer therapies.
- Overview of advancements in cardiovascular diagnostics and clinical integration strategies.
Main Results:
- Cardio-oncology is crucial for managing cardiovascular complications in cancer patients.
- Targeted cancer therapies present unique cardiovascular side effects requiring specific diagnostic and management approaches.
- Integration of cardio-oncology into healthcare systems and standardized guidelines are essential.
Conclusions:
- Continuous scientific and clinical advancements are vital for optimal care of cancer patients with cardiovascular disease.
- Standardized guidelines and educational programs are necessary for the successful development of cardio-oncology.
- Addressing challenges, including those posed by the COVID-19 pandemic, is key for future progress in patient-oriented cardio-oncology care.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
214
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
01:27Coronary Artery Disease V: Interprofessional Care
170
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
01:30Introduction Cardiac Emergencies
239
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
239
01:25Cardiomyopathy I: Introduction and Classification
383
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
383
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
185
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
185
01:29Pathophysiology of Cardiac Performance
1.3K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K